Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Centre for Mendelian Genomics, |
RCV001196643 | SCV001367263 | likely pathogenic | Autosomal recessive nonsyndromic hearing loss 28 | 2019-08-14 | criteria provided, single submitter | clinical testing | This variant was classified as: Likely pathogenic. The following ACMG criteria were applied in classifying this variant: PVS1,PM2. |
Gene |
RCV001587220 | SCV001826151 | likely pathogenic | not provided | 2021-05-17 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Has not been previously published as pathogenic or benign to our knowledge |
Pars Genome Lab | RCV001196643 | SCV002513783 | pathogenic | Autosomal recessive nonsyndromic hearing loss 28 | criteria provided, single submitter | clinical testing | ||
Labcorp Genetics |
RCV001587220 | SCV003483614 | pathogenic | not provided | 2022-07-05 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg1025*) in the TRIOBP gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TRIOBP are known to be pathogenic (PMID: 16385457, 16385458, 20510926). This variant is present in population databases (rs776962899, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with TRIOBP-related conditions. ClinVar contains an entry for this variant (Variation ID: 930753). For these reasons, this variant has been classified as Pathogenic. |